News
Video
Angiogenesis 2024: AVD-104 for Geographic Atrophy
Author(s):
Carl Danzig, MD, sat down with Martin David Harp of Ophthalmology Times to discuss his presentation AVD-104 for Geographic Atrophy: Glyco-immunologic modulation of macrophage activity from the Angiogenesis Exudation and Degeneration 2024 event.
Video Player is loading.
Carl Danzig, MD, sat down with Martin David Harp of Ophthalmology Times to discuss his presentation AVD-104 for Geographic Atrophy: Glyco-immunologic modulation of macrophage activity from the Angiogenesis Exudation and Degeneration 2024 event.
Related Videos
Part 2: Biggest innovations in ophthalmology in 50 years
Part 1: Biggest innovations in ophthalmology in 50 years
World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
Anat Loewenstein comments on the recent FDA approval of revakinagene taroretcel-lwey (ENCELTO) for macular telangiectasia type 2 treatment
EnVision Summit 2025: Glaucoma with co-existing ocular co-morbidities
AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
EnVision Summit 2025: Ergonomics in the operating room
Related Content
